Research publications from Maverex
We share peer-reviewed research publications across oncology, cardiovascular, infectious disease and much more.
Browse or search our latest publications.
Identification of Cost-Effectiveness Evidence in UK NICE Single Technology Assessment Company Submissions: Databases, Sources and Currency of Searching
ISPOR US 2024: Poster Session: 1. May 6th 2024. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
European Health Technology Assessment: Historical Success of European Joint Assessments
ISPOR US 2024: Poster Session: 1. May 6th 2024. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
Systematic Literature Review Requirements for Health Technology Assessment in European Markets
ISPOR US 2024: Poster Session: 3. May 7th 2024. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
Comparison of the Use of Real-World Evidence for Clinical Effectiveness in HTA Pre- and Post- Introduction of the NICE Framework – an Update
ISPOR US 2024: Poster Session: 3. May 7th 2024. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
A Comparative Assessment of Systematic Literature Review Requirements for Health Technology Assessment, Globally
ISPOR Europe 2023: Poster Session: 5. 15 November 2023. Poster Session Time: 9:00 - 11:30. Discussion Period: 9:00 - 10:00.
Surrogate Endpoints Used in NICE Technology Appraisals for Oncology and Non-Oncology Indications, 2022–23
ISPOR Europe 2023: Poster Session: 1. 13 November 2023. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
Comparison of the Use of Real-World Evidence for Clinical Effectiveness in HTA Pre- and Post- Introduction of the NICE Framework
ISPOR Europe 2023: Poster Session: 5. 15 November 2023. Poster Session Time: 9:00-11:30. Discussion Period: 9:00-10:00
Challenges and Solutions to Estimating Environmental Impact in Health Technology Assessment
ISPOR Europe 2023: Poster Session: 4. 14 November 2023. Poster Session Time: 15:30-18:30. Discussion Period: 16:00-17:00
